UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Michael George Francis Crowe

BMJ (Online), 2024-09, p.q1933

Crowe, Alex

2024

Volltextzugriff (PDF)

Case mix, outcome and activity for patients with severe acute kidney injury during the first 24 hours after admission to an adult, general critical care unit: application of predictive models from a secondary analysis of the ICNARC Case Mix Programme database

Critical care (London, England), 2008-01, Vol.12 Suppl 1 (Suppl 1), p.S2-S2, Article S2

2008

Volltextzugriff (PDF)

Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database

Critical care (London, England), 2007-01, Vol.11 (2), p.R50-R50

2007

Volltextzugriff (PDF)

Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care

Frontiers in neurology, 2019-11, Vol.10, p.1116-1116

2019

Volltextzugriff (PDF)

Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening

Biochemistry (Easton), 2009-08, Vol.48 (32), p.7732-7745

2009

Volltextzugriff (PDF)

The Dynamics and Turnover of Tau Aggregates in Cultured Cells

The Journal of biological chemistry, 2016-06, Vol.291 (25), p.13175-13193

2016

Volltextzugriff (PDF)

Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model

The Journal of biological chemistry, 2023-07, Vol.299 (7), p.104876-104876, Article 104876

2023

Volltextzugriff (PDF)

Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation

The Journal of biological chemistry, 2013-04, Vol.288 (16), p.11024-11037

2013

Volltextzugriff (PDF)

Ward round accreditation: an innovative quality improvement project to develop and improve the existing medical ward round at Warrington Hospital

Clinical medicine (London, England), 2019-06, Vol.19 (Suppl 3), p.72-72

2019

Volltextzugriff (PDF)

Ward round accreditation: an innovative quality improvement project to develop and improve the existing medical ward round at Warrington Hospital

Clinical medicine (London, England), 2019-06, Vol.19 (3), p.s72-s72

2019

Volltextzugriff (PDF)

The Dynamics and Turnover of Tau Aggregates in Cultured Cells: INSIGHTS INTO THERAPIES FOR TAUOPATHIES

The Journal of biological chemistry, 2016-06, Vol.291 (25), p.13175-13193

2016

Volltextzugriff (PDF)

MP144AGE ADJUSTED 5 YEARS SURVIVAL OF NEW ANCA ASSOCIATED VASCULITIS PATIENTS TREATED WITH RITUXIMAB AS SINGLE INDUCTION AGENT

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i390-i391

2016

Volltextzugriff (PDF)

Ventriculo‐peritoneal shunt infection in a patient on hemodialysis

Hemodialysis international, 2008-07, Vol.12 (3), p.319-321

2008

Volltextzugriff (PDF)

Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau

Journal of neurochemistry, 2009-08, Vol.110 (4), p.1339-1351

2009

Volltextzugriff (PDF)

Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays

The Journal of biological chemistry, 2020-03, Vol.295 (12), p.4001-4013

2020

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of 1‑Phenylpyrazolo[3,4‑e]pyrrolo[3,4‑g]indolizine-4,6(1H,5H)‑diones as New Glycogen Synthase Kinase-3β Inhibitors

Journal of medicinal chemistry, 2013-12, Vol.56 (24), p.10066-10078

2013

Volltextzugriff (PDF)

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors

Experimental neurology, 2010-06, Vol.223 (2), p.304-310

2010

Volltextzugriff (PDF)

Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report

Journal of medical case reports, 2009-12, Vol.3 (1), p.9321-9321, Article 9321

2009

Volltextzugriff (PDF)

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation

Biochemical and biophysical research communications, 2007-06, Vol.358 (1), p.1-6

2007

Volltextzugriff (PDF)

Developing an online, modular, active learning training program for behavioral activation

Psychotherapy (Chicago, Ill.), 2013-06, Vol.50 (2), p.256-265

2013

Volltextzugriff (PDF)

Aminothienopyridazine inhibitors of tau aggregation: Evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties

Bioorganic & medicinal chemistry, 2012-07, Vol.20 (14), p.4451-4461

2012

Volltextzugriff (PDF)

Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation

Journal of medicinal chemistry, 2010-05, Vol.53 (9), p.3739-3747

2010

Volltextzugriff (PDF)

Tau-directed drug discovery for Alzheimer' s disease and related tauopathies: A focus on tau assembly inhibitors

Experimental neurology, 2010-06, Vol.223 (2), p.304-310

2010

Volltextzugriff (PDF)

Surviving and thriving in the early years as a new consultant physician

Clinical medicine (London, England), 2004-03, Vol.4 (2), p.185-186

Crowe, Alex

2004

Volltextzugriff (PDF)

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors : Beta-amylid and tau protein abnormalities in Alzheimer's disease

Experimental neurology, 2010, Vol.223 (2), p.304-310

2010

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(76)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(97)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Michael George Francis Crowe

Case mix, outcome and activity for patients with severe acute kidney injury during the first 24 hours after admission to an adult, general critical care unit: application of predictive models from a secondary analysis of the ICNARC Case Mix Programme database

Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database

Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care

Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening

The Dynamics and Turnover of Tau Aggregates in Cultured Cells

Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model

Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation

Ward round accreditation: an innovative quality improvement project to develop and improve the existing medical ward round at Warrington Hospital

Ward round accreditation: an innovative quality improvement project to develop and improve the existing medical ward round at Warrington Hospital

The Dynamics and Turnover of Tau Aggregates in Cultured Cells: INSIGHTS INTO THERAPIES FOR TAUOPATHIES

MP144AGE ADJUSTED 5 YEARS SURVIVAL OF NEW ANCA ASSOCIATED VASCULITIS PATIENTS TREATED WITH RITUXIMAB AS SINGLE INDUCTION AGENT

Ventriculo‐peritoneal shunt infection in a patient on hemodialysis

Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau

Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays

Design, Synthesis, and Biological Evaluation of 1‑Phenylpyrazolo[3,4‑e]pyrrolo[3,4‑g]indolizine-4,6(1H,5H)‑diones as New Glycogen Synthase Kinase-3β Inhibitors

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors

Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation

Developing an online, modular, active learning training program for behavioral activation

Aminothienopyridazine inhibitors of tau aggregation: Evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties

Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation

Tau-directed drug discovery for Alzheimer' s disease and related tauopathies: A focus on tau assembly inhibitors

Surviving and thriving in the early years as a new consultant physician

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors : Beta-amylid and tau protein abnormalities in Alzheimer's disease

Suchergebnisse filtern